Presentation TCT 2024 What’s Next in Acute and Chronic Phase Antithrombotic Therapy in ACS Presenter: C. Michael Gibson October 28, 2024
Presentation TCT 2024 Case Presentation: STEMI Patient at High-Bleeding Risk Presenter: Angelo Oliva October 28, 2024
Presentation TCT 2024 TCT 9: Diagnostic Accuracy of CT-FFR and QFR for Coronary Lesion-Specific Ischemia Presenter: Haoyu Wu October 27, 2024
Presentation TCT 2024 TCT 11: Inpatient Outcomes of Non-ST-Elevation Myocardial Infarction Patients on Chronic Anticoagulation: A Nationwide Analysis Presenter: Ahmed Younes October 27, 2024
Presentation TCT 2024 TCT 7: Impact of Use of Proton Pump Inhibitor in Patients Taking Clopidogrel: A Meta-Analysis of Randomized Controlled Trials Presenter: Mobeen Haider October 27, 2024
Presentation TCT 2024 TCT 664: Simplifying Coronary Revascularization in High Bleeding Risk With SCAD or ACS: Sirolimus-DCB & SAPT Presenter: Victor Alfonso Jimenez Diaz October 27, 2024
Presentation TCT 2024 TCT 10: Interference of Fentanyl in the Pharmacodynamics and Pharmacokinetics of Ticagrelor: A Meta-Analysis of Randomized Trials Presenter: BERNARDO KREMER October 27, 2024
Presentation TCT 2024 TCT 228: Treatment Modifications in Ticagrelor-Treated Patients: Insights From the FORCE-ACS Registry Presenter: Niels van der Sangen October 27, 2024
Presentation TCT 2024 TCT 230: Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk: A Post-Hoc Analysis of the TWILIGHT Trial Presenter: Mauro Gitto October 27, 2024
Presentation TCT 2024 TCT 229: Rebound Phenomenon of Platelet Reactivity After Cessation of Long-term Clopidogrel Therapy Presenter: Jung-Kyu Han October 27, 2024
Presentation TCT 2024 TCT 231: Safety of Aspirin-Free Prasugrel Monotherapy After PCI: Pooled Analysis of Three Months Outcomes in 508 Patients From ASET-I and ASET-Japan Trials Presenter: KOTARO MIYASHITA October 27, 2024
Presentation TCT 2024 TCT 227: Timing and Indications for Cangrelor Use and Transition Modalities to Oral P2Y12 Inhibitors in Patients Undergoing PCI: Insights From the SMILE Study Presenter: Angelo Oliva October 27, 2024
Presentation TCT 2024 TCT 4: Rationale and Design of the IMODERN STOP-IMH Randomized Trial: The Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for STEMI and the Effect on Intramyocardial Haemorrhage Presenter: Bahram Yosofi October 27, 2024
Presentation TCT 2024 TCT 1: Differential Outcomes in ST-Elevation and Non-ST Elevation Myocardial Infarction Outcomes After Percutaneous Coronary Intervention With Versus Without Cangrelor Presenter: Andrew Hill October 27, 2024
Presentation TCT 2024 TCT 5: Safety and Efficacy of Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction: A Meta-Analysis of RCTs Presenter: Sheref Elseidy October 27, 2024
Presentation TCT 2024 TCT 3: Ticagrelor Monotherapy After Coronary Stenting in Patients With Acute Myocardial Infarction (TIMO-AMI Study) Presenter: Oskar Angerås October 27, 2024
Presentation TCT 2024 TCT 2: Less Bleeding by Omitting Aspirin in Non-ST-Segment Elevation Acute Coronary Syndrome Patients (LEGACY) Presenter: Shabiga Sivanesan October 27, 2024
Presentation TCT 2024 TCT 6: Aspirin-Free Prasugrel Monotherapy After PCI in Patients With Non-ST Elevation Acute Coronary Syndrome Presenter: KOTARO MIYASHITA October 27, 2024
Presentation TCT 2024 TCT 238: Safety and Efficacy of Cangrelor: A Multicenter Nationwide Registry ARECA (Austrian Registry for Cangrelor Application) Presenter: Guy Friedrich October 27, 2024
Presentation TCT 2024 TCT 234: Sex Differences in the Safety and Efficacy of Short-term DAPT Versus DAPT De-escalation After Percutaneous Coronary Intervention Presenter: Donna Lin October 27, 2024